HETERO LABS UNIT III FDA Approval ANDA 210859

ANDA 210859

HETERO LABS UNIT III

FDA Drug Application

Application #210859

Application Sponsors

ANDA 210859HETERO LABS UNIT III

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2022-04-18STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

HETERO LABS UNIT III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210859
            [companyName] => HETERO LABS UNIT III
            [docInserts] => ["",""]
            [products] => [{"drugName":"EZETIMIBE","activeIngredients":"EZETIMIBE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/18\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-04-18
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.